Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Int J Cardiovasc Imaging ; 23(2): 217-24, 2007 Apr.
Article in English | MEDLINE | ID: mdl-16855858

ABSTRACT

PURPOSE: The purpose of this study is to follow myocardial angiogenesis temporally using quantitative magnetic resonance first pass perfusion imaging and compare this with the "gold standard" of radioactive microspheres in a random subset of animals. MATERIALS AND METHODS: Ameriod constrictors were placed around the left circumflex in 15 pigs to induce an ischemic area. Two groups were randomized to receive either a sham operation or treatment with angiogenic implants inserted into myocardium in the distribution of the left circumflex artery (LCX). These implants are designed to induce myocardial angiogenesis. Magnetic resonance first pass perfusion imaging was performed at baseline and also after treatment with either sham or implant therapy by using first pass perfusion imaging with a TurboFLASH sequence. Absolute myocardial blood flow was derived by applying a quantitative Fermi function model. Radioactive microspheres were also injected into a random subset of animals to measure myocardial blood flow. RESULTS: Angiogenic implant therapy increased absolute myocardial blood flow in the left circumflex territory relative to baseline and sham treated groups during adenosine infusion. Myocardial blood flows measured with radioactive microspheres was increased significantly in both the LCX and LAD territories during stress. Myocardial Perfusion reserve was also significantly increased in both the LCX and left anterior descending territories relative to baseline. Ejection Fraction during stress with dobutamine infusion increased significantly in the implant therapy group while that in the sham group was not affected. CONCLUSION: Quantitative MR myocardial first pass perfusion imaging can be used to track the development of angiogenesis as corroborated by radioactive microspheres. Angiogenic implant therapy is a new device based therapy that has potential to protect an ischemic region by accelerating angiogenesis although further research is necessary with this device.


Subject(s)
Absorbable Implants , Coronary Angiography/methods , Coronary Circulation , Magnetic Resonance Angiography , Myocardial Ischemia/pathology , Myocardial Ischemia/therapy , Neovascularization, Physiologic , Animals , Contrast Media , Disease Models, Animal , Exercise Test , Gadolinium DTPA , Magnetic Resonance Imaging, Cine , Microspheres , Models, Cardiovascular , Myocardial Ischemia/diagnostic imaging , Myocardial Ischemia/physiopathology , Random Allocation , Stroke Volume , Swine , Time Factors
2.
Circulation ; 112(6): 855-61, 2005 Aug 09.
Article in English | MEDLINE | ID: mdl-16087809

ABSTRACT

BACKGROUND: Two-dimensional echocardiography is currently the standard test for the clinical diagnosis of hypertrophic cardiomyopathy (HCM). The present study was undertaken to determine whether cardiac MRI (CMR) affords greater accuracy than echocardiography in establishing the diagnosis and assessing the magnitude of left ventricular (LV) hypertrophy in HCM. METHODS AND RESULTS: Forty-eight patients (age 34+/-16 years) suspected of having HCM (or with a confirmed diagnosis) were imaged by both echocardiography and CMR to assess LV wall thickness in 8 anatomic segments (total n=384 segments) and compared in a blinded fashion. Maximum LV thickness was similar by echocardiography (21.7+/-9.1 mm) and CMR (22.5+/-9.6 mm; P=0.21). However, in 3 (6%) of the 48 patients, echocardiography did not demonstrate LV hypertrophy, and CMR identified otherwise undetected areas of wall thickening in the anterolateral LV free wall (17 to 20 mm), which resulted in a new diagnosis of HCM. In the overall study group, compared with CMR, echocardiography also underestimated the magnitude of hypertrophy in the basal anterolateral free wall (by 20+/-6%; P=0.001), as well as the presence of extreme LV wall thickness (> or =30 mm) in 10% of patients (P<0.05). CONCLUSIONS: CMR is capable of identifying regions of LV hypertrophy not readily recognized by echocardiography and was solely responsible for diagnosis of the HCM phenotype in an important minority of patients. CMR enhances the assessment of LV hypertrophy, particularly in the anterolateral LV free wall, and represents a powerful supplemental imaging test with distinct diagnostic advantages for selected HCM patients.


Subject(s)
Cardiomyopathy, Hypertrophic/diagnosis , Magnetic Resonance Imaging/methods , Adolescent , Adult , Aged , Cardiomyopathy, Hypertrophic/diagnostic imaging , Child , Echocardiography , Female , Heart Failure/etiology , Humans , Male , Middle Aged , Ventricular Dysfunction, Left/pathology
3.
Catheter Cardiovasc Interv ; 61(3): 376-80, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14988899

ABSTRACT

Intravascular ultrasound provides detailed information on vessel wall and plaque morphology. This report illustrates the use of three-dimensional volumetric IVUS reconstruction images to characterize different patterns of plaque morphology, including vulnerable and ruptured plaques, within a single coronary artery in a patient with unstable angina.


Subject(s)
Angina, Unstable/diagnostic imaging , Coronary Artery Disease/diagnostic imaging , Ultrasonography, Interventional , Algorithms , Coronary Stenosis/diagnostic imaging , Humans , Image Processing, Computer-Assisted , Imaging, Three-Dimensional , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...